Free Trial

Bicycle Therapeutics (BCYC) Institutional Ownership

Bicycle Therapeutics logo
$3.51 -0.12 (-3.31%)
Closing price 04:00 PM Eastern
Extended Trading
$3.55 +0.04 (+1.20%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Bicycle Therapeutics (NASDAQ:BCYC)

Current
Institutional Ownership
Percentage
86.15%
Number of
Institutional Buyers
(last 12 months)
49
Total
Institutional Inflows
(last 12 months)
$39.75M
Number of
Institutional Sellers
(last 12 months)
20
Total
Institutional Outflows
(last 12 months)
$18.06M
Get BCYC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicycle Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BCYC Institutional Buying and Selling by Quarter

Bicycle Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/21/2026AXQ Capital LP27,368$116K0.0%-56.7%0.039%
8/13/2026Portland Investment Counsel Inc.15,000$64K0.0%N/A0.021%
7/10/2026Marquette Asset Management LLC72,854$309K0.0%N/A0.104%
7/8/2026FNY Investment Advisers LLC26,250$111K0.0%+247.4%0.038%
7/7/2026GAMMA Investing LLC7,704$33K0.0%+512.9%0.011%
5/19/2026Flax Pond Capital LLC176,136$817K0.7%+1.4%0.253%
5/18/2026ADAR1 Capital Management LLC71,298$331K0.0%N/A0.102%
5/18/2026Royal Bank of Canada14,470$67K0.0%+35.5%0.021%
5/18/2026Eversept Partners LP190,715$885K0.0%+6.6%0.274%
5/15/2026Rangeley Capital LLC232,260$1.08M1.0%+76.0%0.333%
5/14/2026Renaissance Technologies LLC979,300$4.54M0.0%+72.8%1.405%
5/14/2026Siren L.L.C.1,560,882$7.24M0.2%-22.5%2.239%
5/14/2026Sei Investments Co.52,784$245K0.0%+7.6%0.076%
5/4/2026Principal Financial Group Inc.1,174,625$5.45M0.0%+2.3%1.685%
4/29/2026R Squared Ltd21,057$98K0.1%N/A0.030%
3/9/2026Flax Pond Capital LLC173,633$1.23M0.9%N/A0.250%
2/19/2026Invesco Ltd.10,092$71K0.0%N/A0.015%
2/18/2026State of Tennessee Department of Treasury61,153$433K0.0%+36.4%0.088%
2/18/2026XTX Topco Ltd47,674$338K0.0%+309.3%0.069%
2/18/2026Virtus Investment Advisers LLC35,709$253K0.1%+172.7%0.051%
2/18/2026Quadrature Capital Ltd46,728$331K0.0%+67.5%0.067%
2/18/2026Millennium Management LLC326,626$2.31M0.0%-69.0%0.471%
2/18/2026Moore Capital Management LP275,000$1.95M0.0%+120.0%0.396%
2/18/2026Man Group plc42,860$303K0.0%+4.8%0.062%
2/18/2026Engineers Gate Manager LP24,047$170K0.0%+79.2%0.035%
2/18/2026Eversept Partners LP178,915$1.27M0.1%-8.0%0.258%
2/18/2026Armistice Capital LLC3,236,000$22.91M0.3%+8.7%4.665%
2/17/2026Jump Financial LLC31,000$219K0.0%+44.7%0.045%
2/17/2026Price T Rowe Associates Inc. MD1,171,787$8.30M0.0%-15.4%1.689%
2/17/2026Monimus Capital Management LP93,840$664K0.4%+10.1%0.135%
2/17/2026Fcpm Iii Services B.V.3,468,430$24.56M3.3%+0.5%5.000%
2/17/2026Royal Bank of Canada10,682$76K0.0%-16.1%0.015%
2/13/2026Marshall Wace LLP38,795$275K0.0%N/A0.056%
2/13/2026The Manufacturers Life Insurance Company 127,863$869K0.0%-9.0%0.184%
2/13/2026Schroder Investment Management Group584,770$3.98M0.0%N/A0.843%
2/13/2026Birchview Capital LP462,700$3.28M1.9%+200.5%0.667%
2/13/2026State Street Corp70,178$497K0.0%-5.7%0.101%
2/13/2026Vontobel Holding Ltd.10,000$71K0.0%N/A0.014%
2/12/2026Brooklyn Investment Group10,216$69K0.0%N/A0.015%
2/12/2026GSK plc1,529,561$10.83M1.4%N/A2.205%
Here’s Why Trump Won’t End The Iran War (Ad)

Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end.tc pixel

Uncover the real reason Trump may never end this war
2/12/2026Renaissance Technologies LLC566,600$4.01M0.0%+9.2%0.817%
2/12/2026Marex Group plc78,406$555K0.0%N/A0.113%
2/12/2026Alps Advisors Inc.40,995$290K0.0%+69.9%0.059%
2/11/2026Fox Run Management L.L.C.19,771$140K0.0%N/A0.029%
2/11/2026Westfield Capital Management Co. LP3,016,026$21.35M0.1%+2.2%4.348%
2/10/2026TD Asset Management Inc147,992$1.05M0.0%-16.9%0.213%
2/10/2026Goldman Sachs Group Inc.24,732$175K0.0%N/A0.036%
2/9/2026Geode Capital Management LLC25,129$178K0.0%-37.1%0.036%
2/9/2026Clearstead Advisors LLC4,655$33K0.0%+234.2%0.007%
2/9/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.134,689$954K0.0%N/A0.194%
2/9/2026Jefferies Financial Group Inc.297,247$2.11M0.0%-26.0%0.428%
2/6/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.134,689$954K0.0%N/A0.194%
2/5/2026Pinnacle Associates Ltd.190,480$1.35M0.0%-3.1%0.275%
2/2/2026Pinnacle Wealth Management Advisory Group LLC10,000$71K0.0%N/A0.014%
1/14/2026Woodstock Corp29,146$206K0.0%+21.8%0.042%
11/17/2025Armistice Capital LLC2,978,000$23.05M0.3%+6.4%4.293%
11/17/2025Palo Alto Investors LP221,071$1.71M0.3%-11.2%0.319%
11/17/2025Long Focus Capital Management LLC1,418,695$10.98M0.4%+7.7%2.045%
11/17/2025Millennium Management LLC1,054,746$8.16M0.0%-26.9%1.520%
11/17/2025Moore Capital Management LP125,000$968K0.0%+66.7%0.180%
11/17/2025Citadel Advisors LLC189,027$1.46M0.0%+20.3%0.272%
11/17/2025Bank of America Corp DE591,535$4.58M0.0%-28.8%0.853%
11/17/2025Ameriprise Financial Inc.14,972$116K0.0%+21.7%0.022%
11/14/2025Man Group plc40,891$316K0.0%+42.6%0.059%
11/14/2025Two Sigma Investments LP184,537$1.43M0.0%+228.4%0.266%
11/13/2025Platinum Investment Management Ltd.184,603$1.43M0.1%-35.3%0.266%
11/13/2025Tocqueville Asset Management L.P.12,300$95K0.0%-46.3%0.018%
11/13/2025Sei Investments Co.49,056$380K0.0%+361.2%0.071%
11/13/2025Legal & General Group Plc197,917$1.53M0.0%+13.2%0.286%
11/13/2025Jefferies Financial Group Inc.401,926$3.11M0.0%-12.8%0.580%
11/13/2025Pinnacle Associates Ltd.196,618$1.52M0.0%+14.3%0.284%
11/13/2025Dynamic Technology Lab Private Ltd27,959$216K0.0%-39.2%0.040%
11/12/2025Handelsbanken Fonder AB150,000$1.16M0.0%-25.0%0.216%
11/12/2025Westfield Capital Management Co. LP2,952,543$22.85M0.1%+6.2%4.260%
11/10/2025TD Asset Management Inc178,092$1.38M0.0%-7.8%0.257%
11/7/2025State of New Jersey Common Pension Fund D20,105$156K0.0%N/A0.029%
11/6/2025Assetmark Inc.3,625$28K0.0%+74.9%0.005%
11/5/2025Alps Advisors Inc.24,123$187K0.0%-6.3%0.035%
11/4/2025Principal Financial Group Inc.1,148,402$8.89M0.0%+64.7%1.657%
10/31/2025Vanguard Personalized Indexing Management LLC12,953$100K0.0%N/A0.019%
10/15/2025Harbor Capital Advisors Inc.41,368$320K0.0%-70.2%0.060%
8/15/2025State of Tennessee Department of Treasury14,382$100K0.0%N/A0.021%
8/15/2025Soleus Capital Management L.P.100,000$695K0.0%N/A0.144%
8/15/2025Monimus Capital Management LP85,224$592K0.4%N/A0.123%
8/15/2025Rangeley Capital LLC75,000$521K0.6%N/A0.108%
8/15/2025Moore Capital Management LP75,000$521K0.0%+50.0%0.108%
8/15/2025Man Group plc28,675$199K0.0%N/A0.041%
8/15/2025Engineers Gate Manager LP15,402$107K0.0%N/A0.022%
8/15/2025Bank of America Corp DE830,634$5.77M0.0%+47.4%1.199%
8/15/2025Ameriprise Financial Inc.12,304$86K0.0%N/A0.018%
Federal Reserve Reveals Disturbing New Plan To Control Your Money (Ad)

A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.tc pixel

Click here to see the document and learn protective steps
8/14/2025Paloma Partners Management Co39,250$273K0.0%N/A0.057%
8/14/2025Jane Street Group LLC22,607$157K0.0%N/A0.033%
8/14/2025Ausdal Financial Partners Inc.10,000$70K0.0%N/A0.014%
8/14/2025Armistice Capital LLC2,800,000$19.46M0.3%+4.8%4.043%
8/14/2025The Manufacturers Life Insurance Company 140,492$976K0.0%+1.6%0.203%
8/14/2025Sei Investments Co.10,637$74K0.0%N/A0.015%
8/14/2025AXA S.A.280,152$1.95M0.0%-49.4%0.405%
8/13/2025Jump Financial LLC16,740$116K0.0%N/A0.024%
8/13/2025Virtus Investment Advisers LLC10,821$75K0.0%+32.6%0.016%
8/13/2025Quadrature Capital Ltd17,738$123K0.0%N/A0.026%


BCYC Institutional Ownership - Frequently Asked Questions

During the previous two years, 108 institutional investors and hedge funds held shares of Bicycle Therapeutics. The most heavily invested institutionals were Baker BROS. Advisors LP ($152.40M), Point72 Asset Management L.P. ($63.77M), Fcpm Iii Services B.V. ($24.56M), Armistice Capital LLC ($22.91M), Westfield Capital Management Co. LP ($21.35M), Deep Track Capital LP ($17.87M), and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($17.20M).Learn more on Bicycle Therapeutics' institutional investors.

86.15% of Bicycle Therapeutics' stock is owned by institutional investors. Learn more on BCYC's institutional investor holdings.

Of the 86 institutional investors that purchased Bicycle Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($4.50M), Principal Financial Group Inc. ($1.59M), GSK plc ($1.53M), Baker BROS. Advisors LP ($1.49M), Long Focus Capital Management LLC ($1.40M), Fcpm Iii Services B.V. ($1.13M), and Armistice Capital LLC ($1.04M).

Institutional investors have bought a total of 5,768,320 shares in the last 24 months. This purchase volume represents approximately $39.75M in transactions.

Of the 20 institutional investors that sold Bicycle Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.12M), Siren L.L.C. ($451.87K), Bank of America Corp DE ($239.10K), Price T Rowe Associates Inc. MD ($213.01K), Jefferies Financial Group Inc. ($163.85K), Platinum Investment Management Ltd. ($100.78K), and Harbor Capital Advisors Inc. ($97.29K).

Institutional investors have sold a total of 2,627,213 shares in the last 24 months. This volume of shares sold represents approximately $18.06M in transactions.



Institutional ownership data for NASDAQ:BCYC is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/21/2026. New 13F filings are added each quarter as they're published.
From Our Partners